2 No-Brainer Biotech Stocks to Buy Right Now
This pair of names are used to beating the market.
Read MorePosted by Prosper Junior Bakiny, The Motley Fool | Feb 22, 2024
This pair of names are used to beating the market.
Read MorePosted by Prosper Junior Bakiny, The Motley Fool | Feb 9, 2024
These market-beating names could be just getting started.
Read MorePosted by Prosper Junior Bakiny, The Motley Fool | Jan 19, 2024
While the market bounced back last year, these names failed to keep pace with broader equities, yet they remain excellent buys in 2024 and beyond.
Read MorePosted by Prosper Junior Bakiny, The Motley Fool | Aug 4, 2023
It’s been on a roll, and there’s more where that came from…
Read MorePosted by Prosper Junior Bakiny, The Motley Fool | May 25, 2023
With multiple dynamics working in its favor, it has excellent long-term prospects.
Read More